Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $2.42B. Across the group, the median move over the past trading day is +3.63%. Price change over the past year runs from +19.2% to +335.2% across the middle 80 percent of the group, with a median of +250.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% | Oct 19, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% | Oct 8, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% | Sep 29, 2026 |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% | Sep 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.